September 22, 2017
Fresenius Kabi Breaks Ground on $250 million Expansion of Pharmaceutical Manufacturing Site in Illinois
read moreSeptember 12, 2017
Caspofungin Acetate for Injection Now Available from Fresenius Kabi
read moreSeptember 3, 2017
12th Annual Blood Collectors Week Underway
read moreAugust 17, 2017
Fresenius Kabi and AABB Unveil New Website for Annual Blood Collectors Week
read moreJune 1, 2017
Azacitidine for Injection Now Available from Fresenius Kabi
read moreMay 23, 2017
Vecuronium Bromide for Injection Now Available from Fresenius Kabi
read moreMay 16, 2017
Fresenius Kabi Introduces Clofarabine Injection
read moreApril 24, 2017
Fresenius Kabi to Acquire Akorn
read moreApril 13, 2017
Fresenius Kabi Files Amicus Brief in Arkansas
read moreFebruary 16, 2017
Dilaudid® (HYDROmorphone HCl) Injection, USP Now Available in Simplist™ Prefilled Syringes
read moreFebruary 6, 2017
BloodCenter of Wisconsin, Children’s Hospital of Wisconsin, Fresenius Kabi collaborate in first-of-its-kind pilot to track blood digitally
read moreJanuary 23, 2017
APP Pharmaceuticals Settles with the Medicines Company on Angiomax® (Bivalirudin) Patent Litigation
read moreDecember 15, 2016
Fresenius Kabi Introduces Simplist™ Heparin Sodium Injection, USP, Expanding Portfolio of Ready-to-Administer Prefilled Syringes
read moreDecember 14, 2016
Contact RSS Feeds Fresenius Kabi and Terumo Cardiovascular Group Introduce CATSmart Autotransfusion System in the U.S.
read moreDecember 5, 2016
Fresenius Kabi Introduces Tigecycline for Injection, USP
read moreNovember 7, 2016
Fresenius Kabi Introduces Bivalirudin for Injection
read moreOctober 11, 2016
Fresenius Kabi Joins Chicago Health Innovation Incubator MATTER as Newest Strategic Partner
read moreOctober 7, 2016
Fresenius Kabi Receives FDA 510(k) Clearance for the Aurora™ Xi Plasmapheresis System
read moreSeptember 27, 2016
Ketorolac Injection Now Available in 15 mg/mL Simplist™ Prefilled Syringes
read moreSeptember 20, 2016
Fresenius Kabi Introduces Daptomycin for Injection
read moreSeptember 1, 2016
AABB and Fresenius Kabi Launch 11th Annual Blood Collectors Week
read moreAugust 18, 2016
Fresenius Kabi Launches Smoflipid® in the United States
read moreAugust 17, 2016
Fresenius Kabi Announces Major Investment in U.S. Manufacturing
read moreAugust 10, 2016
Fresenius Kabi Releases Lovo Software 2.0
read moreJuly 20, 2016
Fresenius Kabi Introduces Six Presentations of Magnesium Sulfate in Ready-to-Administer Freeflex® Bags
read moreJune 13, 2016
AmeriCares Honors Fresenius Kabi USA with Power of Partnership Award
read moreApril 25, 2016
Fresenius Kabi Issues Voluntary Nationwide Recall of Sensorcaine®-MPF (bupivacaine HCl) Injection, USP due to the Presence of Particulate Matter Characterized as Glass
read moreApril 21, 2016
Fresenius Kabi Introduces Linezolid Injection 600 mg per 300 mL in Freeflex® Bags
read moreFebruary 9, 2016
Dr. Seema Kumbhat Named Fresenius Kabi USA Medical Director
read moreJanuary 8, 2016
Fresenius Kabi USA Acquires U.S. Pharmaceutical Plant and Ready-to-Administer Drugs from BD
read moreJanuary 6, 2016
Fresenius Kabi Continues Key Sponsorship of The Great Chicago Blood Drive
read moreDecember 15, 2015
Fresenius Kabi Initiates Infusion Pump Validation with Leading EMR Company
read moreNovember 30, 2015
Fresenius Kabi Introduces Dexmedetomidine Hydrochloride Injection
read moreSeptember 11, 2015
Fresenius Kabi Introduces Moxifloxacin Injection 400mg per 250mL in Freeflex® Bags
read moreAugust 31, 2015
HealthTrust Names Fresenius Kabi Winner of a 2015 Supplier Excellence Award
read moreAugust 10, 2015
Fresenius Kabi Introduces Cisatracurium Besylate Injection, a New Specialty Injectable Product, in Three Presentations
read moreAugust 3, 2015
Fresenius Kabi Receives FDA Clearance for 7-day Platelet Storage Using Fenwal Amicus® System
read moreJuly 27, 2015
Fresenius Kabi Introduces Glucagon for Injection
read moreJune 24, 2015
Premier Recognizes Fresenius Kabi with Legacy Award for Operational Excellence
read moreJune 11, 2015
Novation recognizes Fresenius Kabi as NOVAPLUS Pharmaceutical Supplier of the Year
read moreJune 1, 2015
Argatroban Injection Now Available from Fresenius Kabi
read moreMay 28, 2015
Fresenius Kabi Recognized by Service Strategies Corp. for Technical Service Excellence
read moreMay 12, 2015
Fresenius Kabi Signs Agreement with Amerinet for Agilia® Large Volume Infusion System
read moreMay 6, 2015
Celebrating the Vital Role of Nurses in America
read moreFebruary 5, 2015
Fresenius Kabi Begins Clinical Trial of the Fenwal Amicus® Red Blood Cell Exchange System to Treat Sickle Cell Disease
read moreFebruary 5, 2015
Fresenius Kabi Begins Clinical Trial of the Fenwal Amicus® Red Blood Cell Exchange System to Treat Sickle Cell Disease
read moreJanuary 19, 2015
Fresenius Kabi Receives FDA Approval for Neostigmine Methylsulfate Injection
read moreJanuary 12, 2015
Fresenius Kabi Receives FDA Status Upgrade for New York Manufacturing Center
read moreJanuary 6, 2015
Fresenius Kabi Introduces NAROPIN® in Freeflex® Bag
read moreDecember 8, 2014
Fresenius Kabi Announces 2014 Inductees for Fenwal Blood Donation Hall of Fame
read moreNovember 17, 2014
Sierra Leone Action Receives Donation of Transfusion Medicine Equipment from Fresenius Kabi
read moreNovember 17, 2014
Sierra Leone Action Receives Donation of Transfusion Medicine Equipment from Fresenius Kabi
read moreSeptember 8, 2014
Blood Collectors Week Celebrates Professionals Who Support the Blood Supply
read moreAugust 26, 2014
Fresenius Kabi Receives FDA approval for Kabiven® and Perikabiven®
read moreAugust 18, 2014
Fresenius Kabi Introduces Acetylcysteine Solution 10% in 4ml, 10ml and 30ml Vials
read moreAugust 11, 2014
Diprivan® (Propofol) Injectable Emulsion, USP Now Available in 10ml Vials
read moreMay 7, 2014
World Premiere Screening of American Nurse Documentary scheduled for May 7, 2014
read moreApril 24, 2014
Fresenius Kabi Introduces Lovo Cell Processing System
read moreApril 2, 2014
Fresenius Kabi Scientific Investigator Award Presented to Dana-Farber Cancer Institute
read moreMarch 24, 2014
Data Regarding Transfusion-Related Reactions for Fenwal InterSol™ Solution
read moreMarch 5, 2014
American Nurses Foundation and Fresenius Kabi USA Host World Premiere Screening of the New Documentary “The American Nurse” May 7, 2014 During Nurses Week
read moreFebruary 24, 2014
Acetylcysteine Solution, USP 20% in 4 mL vials Now Available
read moreDecember 16, 2013
Acetylcysteine Solution, USP 20% in 10 mL vials Now Available from Fresenius Kabi
read moreNovember 19, 2013
FDA Clears New Plasma Protocol Software for Fenwal Alyx® System
read moreOctober 11, 2013
Fresenius Kabi Applauds Missouri Governor for Preventing National Shortage of Anesthesia Drug
read moreAugust 29, 2013
Fresenius Kabi Introduces Levofloxacin IV in Freeflex® Container
read moreJuly 25, 2013
Fenwal Receives 60601-1 3rd Edition Certification for Aurora™ Plasmapheresis System
read moreJune 30, 2013
Fresenius Kabi USA Issues Voluntary Nationwide Recall of Benztropine Mesylate Injection, USP 2 mg/2 mL (1 mg/mL), in 2 mL Single Dose Vials
read moreJune 3, 2013
Fresenius Kabi Named NOVAPLUS® Pharmacy Supplier of the Year
read moreMay 28, 2013
FDA Announces Import of Injectable Nutrition Drugs
read moreMay 25, 2013
Fresenius Kabi USA Initiates Voluntary Recall of Single Lot of Magnesium Sulfate
read moreApril 23, 2013
American Nurses Foundation Announces New Scholarship Fund Supported by Grant from Fresenius Kabi
read moreJanuary 8, 2013
Fresenius Kabi USA Launches Treatment for Acetaminophen Overdose
read moreOctober 1, 2012
Fresenius Kabi Announces Availability of Acetylcysteine Solution, USP
read moreAugust 9, 2012
Fresenius Kabi Announces Launch of Oxaliplatin Injection, USP Latest APP Oncology Product Now Available
read moreMay 23, 2012
APP Pharmaceuticals Acquires Three Products From Nexus. Benztropine Mesylate, Levetiracetam and Tranexamic Acid Injectables are Newest Additions to Critical Care Portfolio
read moreFebruary 22, 2012
APP Pharmaceuticals Announces Approval of Preservative-Free Methotrexate Injection, USP
read moreFebruary 8, 2012
APP Pharmaceuticals Announces Launch of Imipenem and Clilastatin for Injection, USP and Meropenen for Injection, USP
read moreOctober 13, 2011
APP Pharmaceuticals Announces Increased Availability of APP Diprivan® and APP Propofol 1%
read moreJuly 11, 2011
APP Pharmaceuticals Announces Approval and Launch of Clonidine Hydrochloride Injection
read moreJuly 6, 2011
APP Pharmaceuticals Announces Approval of Nafcillin For Injection, USP
read moreJuly 5, 2011
APP Pharmaceuticals Announces Approval Of Levothyroxine Sodium For Injection
read moreJune 15, 2011
APP Pharmaceuticals Invests $38 Million to Expand Its Grand Island, New York Manufacturing Facility
read moreJune 8, 2011
APP Pharmaceuticals Named NOVAPLUS® Pharmacy Manufacturer of the Year
read moreJune 7, 2011
APP Pharmaceuticals to Market Letrozole Tablets, USP in the U.S.
read moreJune 1, 2011
APP Pharmaceuticals Receives Approval for Piperacillin and Tazobactam for Injection
read moreMay 19, 2011
APP Pharmaceuticals Announces Approval and Launch of Gemcitabine HCI for Injection, USP in 2 Gram Dosage Form
read moreMarch 7, 2011
Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 25 to Delist and Deregister Contingent Value Rights for APP Pharmaceuticals
read moreFebruary 23, 2011
Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 10-K for APP Pharmaceuticals, Inc. (APP)
read moreJanuary 26, 2011
APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection
read moreNovember 30, 2010
APP Pharmaceuticals Announces Approval and Launch of Topotecan for Injection
read moreNovember 5, 2010
APP Pharmaceuticals to Launch Drug Hotline
read moreNovember 1, 2010
Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q
read moreOctober 29, 2010
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
read moreAugust 2, 2010
Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q
read moreJuly 6, 2010
APP Pharmaceuticals Announces Marketing Clearance of Preservative-Free Heparin Lock Flush Solution, USP
read moreJune 29, 2010
APP Pharmaceuticals to Market Anastrozole Tablets in the U.S.
read moreJune 22, 2010
APP Pharmaceuticals Announces Approval of Ganciclovir for Injection, USP
read moreJune 21, 2010
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
read moreJune 11, 2010
APP Pharmaceuticals to Market Oxaliplatin Injection (Liquid) in the U.S.
read moreJune 8, 2010
APP Pharmaceuticals Receives Approval for Lyophilized Oxaliplatin for Injection
read moreMay 3, 2010
Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q
read moreApril 1, 2010
Fresenius Kabi Enters Into Licensing and Settlement Agreements with sanofi-aventis
read moreMarch 23, 2010
APP Pharmaceuticals Receives Approval for Indomethacin for Injection
read moreFebruary 23, 2010
Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-K
read moreDecember 2, 2009
Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
read moreNovember 2, 2009
Bernhard Hampl, Ph.D. Elected to Serve as Executive Chairman of the Board of Directors of Fresenius Kabi Pharmaceuticals Holding, Inc.
read moreNovember 2, 2009
Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q
read moreOctober 21, 2009
APP Pharmaceuticals Receives Approval for the First Generic Chlorothiazide Sodium for Injection, USP
read moreOctober 8, 2009
APP Pharmaceuticals Receives Approval for Sumatriptan Succinate Injection, USP
read moreOctober 1, 2009
APP Pharmaceutical Supports New USP Standards for Unfractionated Heparin
read moreSeptember 17, 2009
APP Pharmaceuticals Receives Approval for Deferoxamine Mesylate for Injection, USP
read moreAugust 25, 2009
APP Pharmaceuticals Receives Approval for Penicillin G Potassium for Injection, USP
read moreAugust 10, 2009
APP Pharmaceuticals Receives Approval for Idarubicin HCI Injection
read moreAugust 3, 2009
Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q
read moreApril 29, 2009
Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q
read moreFebruary 18, 2009
FRESENIUS KABI PHARMACEUTICALS HOLDING, INC,ANNOUNCES FILING OF FORM 10-K
read moreJanuary 20, 2009
APP Pharmaceuticals Launches Rocuronium Bromide Injection
read moreDecember 5, 2008
APP Pharmaceuticals Launches Heparin-Focused Educational Web Site Called “Working Together For Patient Safety”
read moreNovember 3, 2008
Fresenius Kabi Pharmaceuticals Holding, Inc. Releases Third Quarter Results
read moreOctober 31, 2008
Fresenius SE Parent Company of Fresenius Kabi Pharmaceuticals Holding, Inc., Announces Date for Third Quarter Earnings
read moreSeptember 10, 2008
APP Pharmaceuticals Announces Completion of Acquisition by Fresenius
read moreJuly 7, 2008
APP Pharmaceuticals to Be Acquired by Fresenius
read more- November 10 - 11, 2017
- USA, Minneapolis, MN
